scPharmaceuticals said in late April that it named pharma-veteran John Tucker as president & CEO, effective immediately. Tucker was also elected to the company’s board of directors.
Tucker formerly served as CEO of Alcresta, where he led regulatory and financing strategies for the company’s 1st product approval and launch. He also worked as Incline Therapeutics’ senior VP and chief commercial officer. His commercial strategy for the company’s lead product helped support the $390 million purchase of Incline by The Medicines Company.
Get the full story at our sister site, Drug Delivery Business News.
The post scPharmaceuticals names Tucker as CEO | Personnel Moves – May 1, 2017 appeared first on MassDevice.